Buch

---

Übersicht

---

Verlag	:	Springer Netherland
Buchreihe	:	Developments in Cardiovascular Medicine (Bd. 50)
Sprache	:	Englisch
Erschienen	:	23. 08. 2014
Seiten	:	366
Einband	:	Kartoniert
Höhe	:	235 mm
Breite	:	155 mm
Gewicht	:	593 g
ISBN	:	9789401087292
Sprache	:	Englisch

---

Inhaltsverzeichnis

---

I. Acute myocardial infarction.- 1. Systemic streptolysis of acute myocardial infarction.- 2. Efficacy of BRL 26921, a new fibrinolytic agent for intravenous infusion, in acute myocardial infarction.- 3. Coronary venous retroperfusion support of reperfusion following acute coronary occlusion.- 4. Elevation of coronary sinus pressure improves myocardial protection.- 5. Improvement of myocardial perfusion and enhancement of washout during coronary artery occlusion by intermittent pressure controlled coronary sinus occlusions.- 6. Medical-mechanical treatment of myocardial infarction.- 7. Autopsy findings in 14 patients with myocardial infarction treated with thrombolysis or combined thrombolysis and PTCA.- 8. Thrombolytic therapy in myocardial infarction: are fibrinolytic drugs comparable, and similarly effective?.- 9. Coronary thrombolysis with tissue-type plasminogen activator (t-PA).- 10. Financial background of PTCR and PTCA and regional distribution of cardiac catheterization laboratories in the Federal Republic of Germany.- II. Evaluation of improvement of myocardial perfusion.- 11. Natural history of coronary artery stenosis.- 12. ECG and reperfusion.- 13. Intracoronary myocardial scintigraphy during intracoronary thrombolysis.- 14. Opposite ends of the intervention spectrum: effects of intracoronary thrombolysis on long-term survival and LV function — Detection of early CAD by non-invasive positron imaging.- 15. Improvement of myocardial perfusion by thrombolysis evaluation of left-ventricular function by two-dimensional echocardiography.- 16. Right ventricular infarction: echocardiographic and hemodynamic feature.- 17. Limitation of myocardial necrosis by thrombolysis during acute myocardial infarction.- III. Percutaneous transluminal coronary angioplasty.- >A.Pathophysiology.- 18. Pathophysiology of transluminal angioplasty.- 19. Does angioplasty improve or accelerate atherosclerosis?.- B. Myocardial function during PTCA.- 20. Elective PTCA of totally occluded coronary arteries not associated with acute myocardial infarction: short and long-term results.- 21. Acute changes of myocardial function by PTCA. Evaluation by two-dimensional echocardiography.- 22. Coronary sinus potassium and pH during percutaneous transluminal angioplasty: temporal relation to contractility and action potential duration.- 23. Validity of myocardial scintigraphy, measurement of pulmonary artery pressure and intravenous digital subtraction angiocardiography in the evaluation of the effect of PTCA.- 24. Monitoring of myocardial ischaemia during PTCA improved sensitivity with 12-lead ECG.- 25. Results of percutaneous transluminal coronary angioplasty assessed by TL-201 perfusion scintigraphy.- 26. Automated computer-assisted quantitative assessment of stenosis geometry and hemodynamics pre and post PTCA.- 27. Relationship of the occlusion pressure during PTCA to collaterals.- 28. Changes in creatine phosphokinase after coronary angioplasty.- 29. Antiischemic properties of intracoronary diltiazem.- 30. Cardio-computertomography for assessing regional myocardial perfusion abnormalities in coronary heart disease.- 31. Clinical significance of microsphere myocardial scintigraphy in coronary artery disease.- C. Clinical results.- 32. Current aspects of transluminal coronary angioplasty.- 33. Treatment of unstable angina by transluminal coronary angioplasty PTCA.- 34. Coronary angioplasty in multivessel disease.- 35. Effect of coronary occlusion during percutaneous transluminal angioplasty on systolic and diastolic left ventricular function.- 36. Restenosisfollowing successful coronary angioplasty (PTCA): the result of inadequate dilatation? — Relation between primary success and late results.- 37. Results of repetitive controls after successful transluminal coronary angioplasty.- 38. Long-term results after angioplasty of stenosed coronary artery bypass grafts.- 39. In vitro studies to investigate the possibility of protective intracoronary perfusion during percutaneous transluminal coronary angioplasty (PTCA).- 40. Haemodynamic and haemorheology effects of intracoronary perfusion during percutaneous transluminal coronary angioplasty (PTCA).- 41. Improved tolerance of intracoronary balloon inflation with a modified Grüntzig balloon angioplasty catheter.- 42. Pressure transmission characteristics of the Grüntzig superlow-profile catheter.- 43. Increased hemolysis during coronary perfusion via angioplasty catheters as a result of side-hole jet effect.- IV. Coronary artery surgery.- 44. Intraoperative angioplasty in the treatment of coronary artery disease.- 45. Treatment of coronary artery stenosis by laser technique.- 46. Reoperative myocardial revascularization.- 47. Aortocoronary polygrafting and coronary endarterectomy in diffuse CAD.- 48. Coronary artery bypass in the elderly.- 49. Combination of valve replacement and coronary bypass.- 50. Cardiac valve replacement and simultaneous myocardial revascularization.- 51. Bypass surgery for stenosis and occlusion of the left main coronary artery.- 52. Bypass surgery adjacent to streptolysis therapy.- 53. Emergency bypass operation after PTCA.- 54. Massive coronary artery spasm with resultant myocardial infarction after ACVB — surgery. A case report.- Index of subjects.

Deine Buchhandlung

---